Toward understanding the neuronal pathogenesis of aspartylglucosaminuria: Expression of aspartylglucosaminidase in brain during development

Molecular Genetics and Metabolism

Volumn 67, Issue 4, 1999, Pages 294-307

  Uusitalo, Annukka ^a   Tenhunen, Kai ^a   Heinonen, Outi ^a   Hiltunen, Jukka O ^b   Saarma, Mart ^b   Haltia, Matti ^c   Jalanko, Anu ^a   Peltonen, Leena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Aspartylglucosaminidase; Aspartylglucosaminuria; Brain; Development; Myelin basic protein

Indexed keywords

MESSENGER RNA; MYELIN BASIC PROTEIN; N4 (BETA N ACETYLGLUCOSAMINYL)ASPARAGINASE;

ADULT; ANIMAL TISSUE; ARTICLE; ASPARTYLGLYCOSAMINURIA; BRAIN DEVELOPMENT; EMBRYO; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFANT; LYSOSOME STORAGE DISEASE; MALE; MENTAL DEFICIENCY; MOUSE; MYELINATION; NEUROPATHOLOGY; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0032818732     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2872     Document Type: Article

References (38)

1. Makino M, Kojima T, Ohgushi T, Yamashina I. Studies on enzymes acting on glycopeptides. J Biochem. 63:1968;186-192.
2. Tenhunen K, Laan M, Manninen T, Palotie A, Peltonen L, Jalanko A. Molecular cloning, chromosomal assignment, and expression of the mouse aspartylglucosaminidase gene. Genomics. 30:1995;244-250.
3. Ikonen E, Baumann M, Grön K, Syvänen A-C, Enomaa N, Halila R, Aula P, Peltonen L. Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO J. 10:1991;51-58.
4. Uusitalo A, Tenhunen K, Tenhunen J, Matikainen S, Peltonen L, Jalanko A. Expression and regulation of the human and mouse aspartylglucosaminidase gene. J Biol Chem. 272:1997;9524-9530.
5. Ikonen E, Julkunen I, Tollersrud O K, Kalkkinen N, Peltonen L. Lysosomal aspartylglucosaminidase is processed to the active subunit complex in the endoplasmic reticulum. EMBO J. 12:1993;295-302.
6. Riikonen A, Rouvinen J, Tikkanen R, Julkunen I, Peltonen L, Jalanko A. Primary folding of aspartylglucosaminidase. J Biol Chem. 271:1996;21340-21344.
7. Oinonen C, Tikkanen R, Rouvinen J, Peltonen L. Three-dimensional structure of human lysosomal aspartylglucosaminidase. Nature Struct Biol. 2:1995;1102-1108.
8. Tikkanen R, Rouvinen J, Törrönen A, Kalkkinen N, Peltonen L. Large-scale purification and preliminary X-ray diffraction studies of glycosylated human aspartylglucosaminidase. Proteins. 24:1996;253-258.
9. Pollit R J, Jenner F A, Merskey H. Aspartylglucosaminuria. An inborn error of metabolism associated with mental defect. Lancet. 2:1968;253-255.
10. Fisher K J, Aronson N N. Deletion of exon 8 causes glycosylasparaginase deficiency in an African American aspartylglucosaminuria (AGU) patient. FEBS Lett. 288:1991;173-178.
11. Ikonen E, Aula P, Grön K, Tollersrud O, Halila R, Manninen T, Syvänen A-C, Peltonen L. Spectrum of mutations in aspartylglucosaminuria. Proc Natl Acad Sci USA. 88:1991;11222-11226.
12. Isoniemi A, Hietala M, Aula P, Jalanko A, Peltonen L. Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene. Hum Mutat. 5:1995;318-326.
13. Jalanko A, Manninen T, Peltonen L. Deletion of the C-terminal end of aspartylglucosaminidase resulting in a lysosomal accumulation disease: Evidence for a unique genomic rearrangement. Hum Mol Genet. 4:1995;435-441.
14. Peltola M, Chiatayat D, Peltonen L, Jalanko A. Characterization of a point mutation in aspartylglucosaminidase gene: Evidence for a readthrough of a translational stop codon. Hum Mol Genet. 3:1994;2237-2242.
15. Peltola M, Tikkanen R, Peltonen L, Jalanko A. Ser72Pro active-site disease mutation in human lysosomal aspartylglucosaminidase: Abnormal intracellular processing and evidence for extracellular activation. Hum Mol Genet. 5:1996;737-743.
16. Jalanko A, Tenhunen K, McKinney C E, LaMarca M E, Rapola J, Autti T, Joensuu R, Manninen T, Sipilä I, Ikonen S, Riekkinen P J, Ginns E I, Peltonen L. Mice with aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients. Hum Mol Genet. 7:1998;265-272.
17. Kaartinen V, Mononen I, Voncken J W, Noronkoski T, Gonzalez-Gomez I, Heisterkamp N, Groffen J. A mouse model for the human lysosomal disease aspartylglycosaminuria. Nature Med. 2:1996;1375-1378.
18. Enomaa N E, Lukinmaa P-L, Ikonen E, Waltimo J C, Palotie A, Paetau A, Peltonen L. Expression of aspartylglucosaminidase in human tissues from normal individuals and aspartylglucosaminuria patients. J Histochem Cytochem. 41:1993;981-989.
19. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor.
20. Wilkinson, D, Green, J. In situ hybridization and the three-dimensional reconstruction of serial sections. In Postimplantation in Mammalian Embryos: A Practical Approach (Copp A, Cockroft, D, Eds.), Oxford, IRL Press, 1990, pp 151-171.
21. Pirvola U, Ylikoski J, Palgi J, Lehtonen E, Arumae U, Saarma M. Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc Natl Acad Sci USA. 89:1992;9915-9919.
22. Halila R, Baumann M, Ikonen E, Enomaa N, Peltonen L. Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structure. Biochem J. 276:1991;251-256.
23. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 72:1976;248-254.
24. Reissig J, Strominger J, Leloir L. A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem. 217:1955;959-966.
25. Vesa J, Hellsten E, Verkruyse L, Camp L, Rapola J, Santavuori P, Hofmann S, Peltonen L. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature. 376:1995;584-587.
26. Palo J, Riekkinen P, Arstila A U, Autio S, Kivimaki T. Aspartylglucosaminuria. II. Biochemical studies on brain, liver, kidney and spleen. Acta Neuropathol. 20:1972;217-224.
27. Kyttälä A, Heinonen O, Peltonen L, Jalanko A. Expression and Endocytosis of lysosomal aspartylglucosaminidase in mouse primary neurons. J Neurosci. 18:1998;7750-7756.
28. Hendelman W J, Aggerwal A S. The Purkinje neuron: I. A Golgi study of its development in the mouse and in culture. J Comp Neurol. 193:1980;1063-1079.
29. Zecevic N, Rakic P. Differentiation of Purkinje cells and their relationship to other components of developing cerebellar cortex in man. J Comp Neurol. 167:1976;27-47.
30. Jacobson M. Developmental Neurobiology. 1991;Plenum Press, New York. p. 421.
31. Sorg B A, Smith M M, Campagnoni A T. Developmental expression of the myelin proteolipid protein and basic protein mRNAs in normal and dysmyelinating mutant mice. J Neurochem. 49:1987;1146-1154.
32. Verity A N, Campagnoni A T. Regional expression of myelin protein genes in the developing mouse brain: In situ hybridization studies. J Neurosci Res. 21:1988;238-248.
33. Amur-Umarjee S, Phan T, Campagnoni A T. Myelin basic protein mRNA translocation in oligodendrocytes is inhibited by astrocytes in vitro. J Neurosci Res. 36:1993;99-110.
34. Amur-Umarjee S, Schonmann V, Campagnoni A T. Neuronal regulation of myelin basic protein mRNA translocation in oligodendrocytes is mediated by platelet-derived growth factor. Dev Neurosci. 19:1997;143-151.
35. Landry C F, Ellison J A, Pribyl T M, Campagnoni C, Kampf K, Campagnoni A T. Myelin basic protein gene expression in neurons: Developmental and regional changes in protein targeting within neuronal nuclei, cell bodies, and processes. J Neurosci. 16:1996;2452-2462.
36. Tenhunen K, Uusitalo A, Autti T, Joensuu R, Kettunen M, Kauppinen R A, Ikonen S, LaMarca M E, Haltia M, Ginns E I, Jalanko A, Peltonen L. Monitoring the CNS pathology in aspartylglucosaminuria mice. J Neuropath Exper Neurol. 57:1998;1154-1163.
37. Autti T, Raininko R, Haltia M, Lauronen L, Vanhanen S L, Salonen O, Aronen H J, Wirtavuori K, Santavuori P. Aspartylglucosaminuria - Radiologic course of the disease with histopathologic correlation. J Child Neurol. 12:1997;369-375.
38. Kaartinen, V, Williams, J, C, Tomich, J, Yates, J, R, Hood, L, E, Mononen, I. Glycosaparaginase from human leukocytes. Inactivation and covalent modification with diazo-oxonorvaline. J Biol Chem266:5860-5869, 1991.